Replies to post #214177 on Biotech Values

[DewDiligence]

MYL/MNTA are developing an Eylea FoB:

https://finance.yahoo.com/news/momenta-mylan-announce-development-strategy-210500734.html

I thought this product candidate, which was codenamed M710, was a Xolair FoB. I’m not convinced that Eylea is a better choice: #msg-137525788.